Results 161 to 170 of about 3,155,046 (320)
Electric Pulse Regulated MXene Based Nanozymes for Integrative Bioelectricity Immuno‐Cancer Therapy
MXenzyme‐mediated bioelectricity cancer therapy (MXenzyme‐BECT) enhances cancer cell death through irreversible depolarization, ion channel disruption, ROS generation, and immunogenic cell death. Computational simulations reveal the electrical mechanisms by which MXenzyme acts on single cells and support to predict treatment parameters. Next‐generation
Sanghee Lee+6 more
wiley +1 more source
Exosomes reveal the dual nature of radiotherapy in tumor immunology. [PDF]
Hu X, Qiu Y, Zeng X, Wang H.
europepmc +1 more source
Tumor immunology and immunotherapy
absent
Svirshchevskaya, E.V.+3 more
openaire +2 more sources
A multifunctional hydroxyapatite (HAp) coating integrated with silver‐gallium liquid metal nanoparticles (HAp‐Ag‐GaNPs) exhibits dual antibacterial and osteogenic properties. It effectively inhibits Gram‐positive and Gram‐negative bacteria, including resistant strains, while enhancing bone regeneration.
Ngoc Huu Nguyen+17 more
wiley +1 more source
Bacteria and tumor: Understanding the roles of bacteria in tumor genesis and immunology.
Mingming Zhao+4 more
semanticscholar +1 more source
This review highlights recent advances in engineering artificial antigen‐presenting cells (aAPCs) as alternatives to dendritic cells for T cell expansion. Key design principles inspired by the immunological synapse are discussed, with emphasis on strategies for polyclonal and antigen‐specific T cell expansion.
Nguyen Thi Nguyen, Yu Seok Youn
wiley +1 more source
Matrix Tropism Influences Endometriotic Cell Attachment Patterns
The influence of substrate stiffness and multicellular coculture on endometriotic cell attachment to extracellular matrix‐laden microarrayed islands is reported. This model investigates early endometriotic cell attachment, aiming to capture “lesion initiation events”.
Hannah S. Theriault+7 more
wiley +1 more source
A review of recent advances on single use of antibody-drug conjugates or combination with tumor immunology therapy for gynecologic cancer. [PDF]
Wang AJ, Gao Y, Shi YY, Dai MY, Cai HB.
europepmc +1 more source